Twist Bioscience (TWST) EBIAT: 2018-2025
Historic EBIAT for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to -$27.2 million.
- Twist Bioscience's EBIAT rose 21.54% to -$27.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$77.7 million, marking a year-over-year increase of 62.78%. This contributed to the annual value of -$77.7 million for FY2025, which is 62.77% up from last year.
- Per Twist Bioscience's latest filing, its EBIAT stood at -$27.2 million for Q3 2025, which was down 233.18% from $20.4 million recorded in Q2 2025.
- Twist Bioscience's 5-year EBIAT high stood at $20.4 million for Q2 2025, and its period low was -$85.6 million during Q2 2024.
- Moreover, its 3-year median value for EBIAT was -$43.0 million (2023), whereas its average is -$40.8 million.
- As far as peak fluctuations go, Twist Bioscience's EBIAT tumbled by 69.59% in 2021, and later spiked by 123.83% in 2025.
- Twist Bioscience's EBIAT (Quarterly) stood at -$45.6 million in 2021, then climbed by 8.21% to -$41.8 million in 2022, then declined by 2.83% to -$43.0 million in 2023, then climbed by 26.53% to -$31.6 million in 2024, then grew by 21.54% to -$27.2 million in 2025.
- Its EBIAT was -$27.2 million in Q3 2025, compared to $20.4 million in Q2 2025 and -$39.3 million in Q1 2025.